On March 13, 2019, Marc Ullman will be a presenter in an EAS Consulting Group webinar entitled “What Does the 2018 Farm Bill Mean for the Cannabis Industry?” The webinar will offer an informative discussion on the FDA’s position on cannabis and how the patchwork of state regulations makes the topic confusing.

Accompanying Marc will

Marc Ullman was quoted in the Nutraingredients-USA article, “Hemp and CBD in pet supplements weaves same tangled web as in products meant for humans.” The focus of the article is the regulatory gray area for hemp and CBD in supplements intended for animals.

Ullman noted, “FDA has been very quiet in this area. CB in pet

Robert H. Iseman was featured prominently in Relias Media’s Healthcare Risk Management newsletter.

In the article, “FTC Investigations Could Bring Unwanted Scrutiny to Hospitals,” Bob notes that hospitals and health systems with “must have” status face substantial antitrust risk. He also suggests that the increased focus on anti-steering provisions is due to two pending cases.

On January 15, Marc Ullman will be speaking at the New York State Bar Association’s “Hot Topics in Cannabis Law 2019: What Lawyers Need to Know.”

He will be speaking on the topic of “CBD: What is it and What it Can Be.”

1. 0 CLE credit in the Areas of Professional Practice being offered.

Marc Ullman was interviewed for a January 2, 2019, article in Life Science Leader magazine entitled “The Unique Challenges Facing Cannabis-based Pharma.” The story covers the lengthy process to get Epidiolex, the first ever pharmaceutical derived from cannabis, approved for medical use.

Marc noted that GW Pharmaceuticals, which developed Epidiolex, was successful because it is

Eric Fader was quoted in a January 1, 2019, Law360 story entitled “Health Care Policy Moves To Watch In 2019.” The article details the health policy developments that attorneys should continue to monitor in 2019.

Eric discusses how U.S. Department of Health and Human Services’ Office for Civil Rights (OCR), which oversees patient privacy safeguards

UNIONDALE, NEW YORK – January 2, 2019 – Evan H. Krinick, Managing Partner of Rivkin Radler LLP, is pleased to announce that Frank Izzo, Gene Kang and Henry Mascia have been elected Partners. “These attorneys are excellent advocates in their varying practice areas with great commitment to our clients…We are proud to have them join

On behalf of a client, Marc Ullman helped secure a decision by the Arizona State Board of Pharmacy to withdraw its attempt to regulate the dietary supplement industry at the state level.

The matter arose when the client, a dietary supplement distributor, received the Board’s demand that it register with the state as a Non-Resident

ALBANY, NY – Rivkin Radler is proud to announce that Robert Iseman was chosen as a winner of the 2019 International Advisory Experts (IAE) Award. The annual awards pay tribute to firms and attorneys who have been successful over the past 12 months and have received exceptional praise from their peers. Winners are chosen by

On December 14, Marc Ullman will be participating in the Hemp CBD Legal Roundtable at the Governor’s Office in NYC.

The roundtable will be facilitated by Axel Bernabe, Assistant Counsel to the Governor, Scott Wyner, General Counsel of the Department of Agriculture and Markets, and Brian Malkin, Co-Chair of the New York State Bar Association’s